Translation elongation factor 2 is part of the target for a new family of antifungals

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 10, 1998, Pages 2694-2699

  Capa, Laura ^a   Mendoza, Alfonso ^a   Lavandera, José L ^a   Gómez De Las Heras, Federico ^a   García Bustos, José F ^a  

^a GLAXOSMITHKLINE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ELONGATION FACTOR 2; GM 135402; GM 160575; GM 163420; GM 165119; GM 193663; GM 237354; RIBOSOME PROTEIN; SORDARIN; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG PROTEIN BINDING; GENE MUTATION; GENETIC COMPLEMENTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA TRANSLATION; SACCHAROMYCES CEREVISIAE; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0031662783     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.10.2694     Document Type: Article

References (25)

1. AEvarsson, A., E. Brazhnikov, M. Garber, J. Zheltonosova, Y. Chirgadze, S. al Karadaghi, L. A. Svensson, and A. Liljas. 1994. Three-dimensional structure of the ribosomal translocase: elongation factor G from Thermus thermophilus. EMBO J. 13:3669-3677.
2. Amils, R., L. Ramirez, J. L. Sanz, I. Marin, A. G. Pisabarro, E. Sanchez, and D. Ureña. 1990. Phylogeny of antibiotic action, p. 645-654. In W. E. Hill, A. Dahlberg, R. A. Garrett, P. B. Moore, D. Schlessinger, and J. R. Warner (ed.), The ribosome: structure, function and evolution. American Society for Microbiology, Washington, D.C.
3. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1997. Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
4. Belfield, G. P., and M. F. Tuite. 1993. Translation elongation factor 3: a fungus-specific translation factor? Mol. Microhiol. 9:411-418.
5. Colthurst, D. R., P. Chalk, M. Hayes, and M. F. Tuite. 1991. Efficient translation of synthetic and natural mRNAs in an mRNA-dependent cell-free system from the dimorphic fungus Candida albicans. J. Gen. Microhiol. 137:851-857.
6. Coval, S. J., M. S. Puar, D. W. Phife, J. S. Terracciano, and M. Patel. 1995. SCH57404, an antifungal agent possessing the rare sordaricin skeleton and a tricyclic sugar moiety. J. Antibiot. 48:1171-1172.
7. Czworkowski, J., J. Wang, T. A. Steitz, and P. B. Moore. 1994. The crystal structure of elongation factor g complexed with GDP, at 2.7 angstrom resolution. EMBO J. 13:3661-3668.
8. Dauber-Osguthorpe, P., V. A. Roberst, and J. Wolff. 1992. Structure and energetics of ligand binding to proteins: E. coli dihydrofolate reductase-trimethoprim, a drug-receptor system. Proteins 4:409-417.
9. Dennis, P. P. 1997. Ancient ciphers - translation in Archaea. Cell 89:1007-1010.
10. Dominguez, J. M., V. A. Kelly, O. S. Kinsman, M. S. Marriott, F. Gomez de las Heras, and J. J. Martin. 1998. Sordarins: a new class of antifungals with selective inhibition of the protein synthesis elongation cycle in yeast. Antimicrob. Agents Chemother. 42:2274-2278.
11. Dominguez, J. M., and J. J. Martin. 1998. Identification of elongation factor 2 as the essential protein targeted by sordarins in Candida albicans. Antimicrob. Agents Chemother. 42:2279-2283.
12. Guthrie, C., and G. R. Fink. 1991. Methods in enzymology, vol. 194. Guide to yeast genetics and molecular biology. Academic Press Inc., San Diego, Calif.
13. Hauser, D., and H. P. Sigg. 1971. Isolierung und Abbau von Sordarin. [Isolation and decomposition of sordarin.] Helv. Chim. Acta 54:1178-1190.
14. Ito, H., Y. Fukuda, K. Murata, and A. Kimura. 1983. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153:163-168.
15. Justice, M. C., M. J. Hsu, B. Tse, T. Ku, J. Balkovec, D. Schmatz, and J. Nielsen. 1998. Elongation factor 2 as a novel target for selective inhibition of fungal protein synthesis. J. Biol. Chem. 273:3148-3151.
16. Kinsman, O. S., P. A. Chalk, H. C. Jackson, R. F. Middleton, A. Shuttleworth, B. A. M. Rudd, C. A. Jones, H. M. Noble, H. G. Wildman, M. J. Dawson, C. Stylli, P. J. Sidebottom, B. Lamont, S. Lynn, and M. V. Hayes. 1998. Isolation and characterisation of an antifungal antibiotic (GR135402) with protein synthesis inhibition. J. Antibiot. 51:41-49.
17. Laskowski, R. A., M. W. MacArthur, D. S. Moss, and J. M. Thornton. 1993. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:283-291.
18. Nissen, P., M. Kjeldgaard, S. Thirup, G. Polekhina, L. Reshetnikova, B. F. Clark, and J. Nyborg. 1995. Crystal structure of the ternary complex of Phe-tRNAPhe, EF-Tu, and a GTP analog. Science 270:1464-1472.
19. Nyborg, J., P. Nissen, M. Kjeldgaard, S. Thirup, G. Polekhina, B. F. C. Clark, and L. Reshetnikova. 1996. Structure of the ternary complex of EF-Tu: macromolecular mimicry in translation. Trends Biochem. Sci. 21:81-82.
20. Orita, M., H. Iwahana, H. Kanazawa, K. Hayashi, and T. Sekiya. 1989. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA 86:2766-2770.
21. Perentesis, J. P., L. D. Phan, W. B. Gleason, D. C. LaPorte, D. M. Livingston, and J. W. Bodley. 1992. Saccharomyces cerevisiae elongation factor 2. Genetic cloning, characterization of expression, and G-domain modeling. J. Biol. Chem. 267:1190-1197.
22. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
23. Schneider, G., H. Anke, and O. Sterner. 1995. Xylarin, an antifungal Xylaria metabolite with an unusual tricyclic uronic acid moiety. Nat. Prod. Lett. 7:309-316.
24. Veldman, S., S. Rao, and J. W. Bodley. 1994. Differential transcription of the two Saccharomyces cerevisiae genes encoding elongation factor 2. Gene 148:143-147.
25. Wilson, K. S., and H. F. Noller. 1998. Mapping the position of translational elongation factor EF-G in the ribosome by directed hydroxyl radical probing. Cell 92:131-139.